Evidence map›Paper›PMID 40277369›Full record

ArticleStatistics in medicine2025

Joint Latent Class Models: A Tutorial on Practical Applications in Clinical Research.

Maéva Kyheng, Génia Babykina, Alain Duhamel

Abstract read
In one paragraph

Article in Statistics in medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Maéva KyhengULR 2694 - METRICS - Évaluation des Technologies de Santé et des Pratiques Médicales, CHU Lille, Université de Lille, Lille, France.ORCID https://orcid.org/0009-0004-7244-1267
Génia BabykinaULR 2694 - METRICS - Évaluation des Technologies de Santé et des Pratiques Médicales, CHU Lille, Université de Lille, Lille, France.
Alain DuhamelULR 2694 - METRICS - Évaluation des Technologies de Santé et des Pratiques Médicales, CHU Lille, Université de Lille, Lille, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Joint latent class model is a statistical approach allowing to simultaneously account for two outcomes related to disease progression: A longitudinal measure (for example a biomarker) and time-to-event, in the context of a heterogeneous population. Within this approach, the linear mixed model, describing the longitudinal measure, is connected to the survival model, describing the risk of event occurrence, via a model for latent classes, describing an unobserved population heterogeneity; thus, the behavior of the two outcomes is assumed to be specific to each latent class. The theoretical properties of the model are established and the model is implemented in software. However, its complexity makes it difficult to manipulate by clinicians. In this paper, we propose a detailed tutorial for clinicians and applied statisticians on how to specify the model in R software in order to respond to concrete clinical questions, how to explore, manipulate, interpret the provided results. The tutorial is based on a real clinical dataset; for each clinical question the mathematical model specification and the R script for implementation are provided, and the estimation results and goodness-of-fit measures are detailed and interpreted.

Indexed as

Biomedical ResearchLatent Class AnalysisModels, StatisticalComputer SimulationData Interpretation, StatisticalDisease ProgressionHumansLinear ModelsLongitudinal StudiesSoftwareSurvival Analysisamyotrophic lateral sclerosisjoint modellatent classeslinear mixed modelsurvival analysistutorial

Identifiers

PMID40277369
PMCPMC12023844

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.